AU2175299A - Hiv inhibition using ligand for gp60 receptor or albumin receptor on target cells - Google Patents

Hiv inhibition using ligand for gp60 receptor or albumin receptor on target cells

Info

Publication number
AU2175299A
AU2175299A AU21752/99A AU2175299A AU2175299A AU 2175299 A AU2175299 A AU 2175299A AU 21752/99 A AU21752/99 A AU 21752/99A AU 2175299 A AU2175299 A AU 2175299A AU 2175299 A AU2175299 A AU 2175299A
Authority
AU
Australia
Prior art keywords
receptor
ligand
target cells
albumin
hiv inhibition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21752/99A
Inventor
Paul Stuart O'Shea
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quadrant Healthcare UK Ltd
Original Assignee
Quadrant Healthcare UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadrant Healthcare UK Ltd filed Critical Quadrant Healthcare UK Ltd
Publication of AU2175299A publication Critical patent/AU2175299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU21752/99A 1998-01-19 1999-01-19 Hiv inhibition using ligand for gp60 receptor or albumin receptor on target cells Abandoned AU2175299A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9801070 1998-01-19
GBGB9801070.5A GB9801070D0 (en) 1998-01-19 1998-01-19 HIV inhibition
PCT/GB1999/000174 WO1999036092A2 (en) 1998-01-19 1999-01-19 Hiv inhibition using ligand for gp60 receptor or albumin receptor on target cells

Publications (1)

Publication Number Publication Date
AU2175299A true AU2175299A (en) 1999-08-02

Family

ID=10825503

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21752/99A Abandoned AU2175299A (en) 1998-01-19 1999-01-19 Hiv inhibition using ligand for gp60 receptor or albumin receptor on target cells

Country Status (3)

Country Link
AU (1) AU2175299A (en)
GB (1) GB9801070D0 (en)
WO (1) WO1999036092A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9930160D0 (en) * 1999-12-22 2000-02-09 Biovector Solutions Limited Drug delivery

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01217540A (en) * 1988-02-25 1989-08-31 Toshiba Corp Document preparing device
WO1994002505A1 (en) * 1992-07-20 1994-02-03 Duke University Compounds which inhibit hiv replication
HUP9900017A3 (en) * 1995-09-21 2001-08-28 Andaris Ltd Ruddington Transcytosis vehicles and enhancers for drug delivery

Also Published As

Publication number Publication date
WO1999036092A3 (en) 1999-10-28
WO1999036092A2 (en) 1999-07-22
GB9801070D0 (en) 1998-03-18

Similar Documents

Publication Publication Date Title
AU2131200A (en) Wide area item tracking system
AU2481999A (en) Solid state director for beams
AU2886799A (en) Monolithic tablet for controlled drug release
AU5759999A (en) Pyrimidone derivatives
AU1616497A (en) Six-degree tracking system
AU2341300A (en) Improved projectile tracking system
AU7136900A (en) System for maintaining precomputed views
AU1155600A (en) System for secure transactions
AU3734799A (en) 5-demethoxyfumagillol derivatives and processes for preparing the same
AU5280998A (en) 8-substituted-1,3,8-triaza-spiro(4.5)decan-4-on derivatives
AU3195499A (en) Feature tracking using a dense feature array
AU3289299A (en) Antiviral agents
AU4549699A (en) Centerfill delivery system for nutraceuticals
AU6086398A (en) Image-directed active range finding system
AU6020898A (en) Substituted bis-acridines and related compounds as ccr5 receptor ligands, anti-inflammatory agents and anti-viral agents
AU1541900A (en) Quick change battery system
AUPO865797A0 (en) Range finding
AU2923799A (en) Target detection arrangement
AU3352899A (en) 2,4,6-trisubstituted pyridines with estrogenic activity and methods for the solid phase synthesis thereof
AU2175299A (en) Hiv inhibition using ligand for gp60 receptor or albumin receptor on target cells
AU5627798A (en) Rock-bolt plate
AU3467197A (en) Tetracyclical derivatives from pyrimidine
AU8800398A (en) 2-(2-methylphenyl)-oxazolines
AU3179699A (en) Intentional sidelobe creation
AU1889800A (en) Clad metal plate for battery case, battery case and battery using the battery case

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase